European Companies Search Engine
Registration · Managing Director: Robert von der Crone · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb31 Oct 2008 German Trade Register Announcements, Germany (29/10/2008)
Overview
Text
Rodos BioTarget GmbH, Hannover (
Unnamed street ??, 30625 Hannover, Germany
). GmbH. Social contract of September 29, 2008. Subject: Research and development as well as the exploitation of research and development results in the field of biomedicine, in particular means of transport for medicinal products and medicinal products mainly for infectious diseases and cancers, but no activity subject to authorisation under the Medicines Act. shareholding in other undertakings of the same or similar nature. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. Gieseler - von der Crone, Robert, Essen, *??.??.????, with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Rodos BioTarget GmbH, Hanover, Germany.